From Nivio, & Only Rs 4,999/-

Computing Without a Computer!

Nivio (www.nivio.com), the world's first online Windows desktop, unveiled the nivioCompanion in India; a tiny US$100 set-top box device with big ambitions and the power of Nivio behind it.  nivioCompanion works just like a normal Windows desktop except that it is run on the internet instead of locally, on a computer. Because everything is run from and stored on the internet, Nivio is: -          familiar. Just like a traditional PC, Nivio is powered by Microsoft Windows. Users can also access programs they're familiar with like iTunes, Skype, MSN Messenger or Microsoft Word, Excel or PowerPoint. -          future proof. all performance updates happen online so nothing ever goes out of date. -          secure. Files are automatically backed-up daily and kept safe and private just like an online vault. There's no need to worry about viruses either, as all virus security is managed by Nivio.  -          simple to use. New programs can be added in seconds without installation, and users only pay for what they use on a monthly basis.  -          accessible anywhere. A virtual Nivio computer is only as far away as the nearest internet-connected device. All files are stored online in the same way as photos are saved online with Flickr or emails are stored on Hotmail. Users simply go to the Nivio website and log in.  Nivio has initially partnered with Bharti Airtel Limited, India's largest telecommunications company, to offer consumers low cost, high powered computing. Together, they hope to extend access to computing for those in India who don't currently own a computer. The first stage of the launch is a limited release launch in New Delhi and the NCR region followed by a national roll-out. Over the next few months, nivioCompanions will also be available through a partnership with Next Retail in the Delhi NCR Region in selected stores (http://www.nivio.com/NEXTStores).   nivioCompanion costs from just Rs4999 (approx US$100) for a standalone device. It is also available with a 15" LCD screen, keyboard and mouse for Rs7999 (approx US$160). Once connected to a broadband internet connection, the nivioCompanion offers a full Windows XP experience complete with a full version of Microsoft Office (and the option to rent other software from leading publishers) and 10GB of storage. Says Sachin Duggal, President & CEO, Nivio, "There are two ways to make computing affordable - one is to give an inferior cut-down offering and the other is to make the whole ecosystem more efficient by offloading the work to the internet. The latter is what we do at Nivio. The launch of the nivioCompanion today marks the start of a new era in smart and low cost computing - powered by an online grid computer; a bit like how homes get electricity.  "We now have over 80,000 Nivio customers and they asked us repeatedly for different ways to connect to Nivio; we listened, researched and developed the nivioCompanion, the first of many nivioEnabled devices. While this is our first piece of hardware, our specialism is software and we've been busy building an eco-system with hardware partners to create more devices to connect with our world-first service. As they say - watch this space, Nivio is very much "always turned on!""  About Nivio Nivio is a computing company that provides a full virtual Windows Desktop, via any internet connected computer or device. This expands access to modern computing and makes it as simple as cable TV. Globally, users can enjoy computing without the headaches of installing software, upgrading, fighting viruses and data loss. Nivio were recently awarded the Technology Pioneer Award at the 2009 World Economic Forum (WEF) joining an elite group of visionary companies chosen for innovations which will have a world-changing impact on society and businesses.

Know Your BOTOX®"
As part of its consumer education campaign, Allergan India aims to address the myths and facts about the use of BOTOX® and encourage women interested in the product to seek advice from a trained and qualified physician specialized in medical aesthetics.  This campaign aims to reach out to consumers and address their questions through a more personalized approach. Specifically, a direct helpline 18002666768 will provide consumers with answers to any questions that they may have and facilitate their access to physicians and medically appropriate clinics as BOTOX® can only be prescribed by a registered healthcare practitioner. About BOTOX®   BOTOX® (Botulinum Toxin Type A) is a prescription-only medical product that contains tiny amounts of highly purified botulinum toxin protein refined from the bacterium, Clostridium botulinum.  When injected at approved and labeled doses into a specific muscle or gland, BOTOX® is expected to diffuse locally and expected to produce a safe and effective result by producing a localized and temporary reduction in the overacting muscle or gland, usually lasting up to 3-6.7 months depending on the individual patient and indication. BOTOX® was first approved by the U.S. Food and Drug Administration (FDA) nearly twenty years ago for the treatment of strabismus and blepharospasm, two eye muscle disorders, making it the first botulinum toxin type A product approved in the world.  Since its first approval, BOTOX® has been recognized by regulatory authorities worldwide as an effective treatment for 21 different indications in approximately 80 countries, benefiting millions of patients worldwide.   In addition to its therapeutic uses, the same formulation of BOTOX® with dosing specific to glabellar lines was approved by the FDA in 2002 under the trade name BOTOX® Cosmetic. BOTOX® Cosmetic has been ranked as the number one physician-administered, aesthetic injectable treatment in the United States for seven years in a row.  High patient satisfaction rates following treatment with BOTOX® Cosmetic have been well established with 97 percent of patients indicating satisfaction with the product, according to a survey of approximately 1,000 patients conducted by the research arm of the American Society for Aesthetic Plastic Surgery (ASAPS).

In addition to nearly 20 years of clinical experience, the safety and efficacy of BOTOX® have been well-established in approximately 50 randomized, placebo-controlled clinical trials and in approximately 11,000 patients treated with BOTOX® and BOTOX® Cosmetic in Allergan's clinical trials[i].    Worldwide, approximately 22 million vials of BOTOX® and BOTOX® Cosmetic have been distributed over the past 20 years (1989-2008)[ii], and nearly 17 million treatment sessions with BOTOX® and BOTOX® Cosmetic have been performed in the United States alone over the past 14 years (1994-2008).[iii] In India, BOTOX® was first approved in 2006 for use in hyperkinetic facial lines and hyperhidrosis, a severe medical condition characterized by excessive sweating.    About Allergan: Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential - to see more clearly, move more freely, express themselves more fully. The Company employs approximately 8,000 people worldwide and operates state-of-the-art R&D facilities and world-class manufacturing plants. In addition to its discovery-to-development research organization, Allergan has global marketing and sales capabilities with a presence in more than 100 countries.